Sign in

CIK 0001321834 · Non-accelerated filer<br>Smaller reporting company

Q/C TECHNOLOGIES, INC.

Sign in to watch
Ticker
QCLS
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
856-848-8698
Business address
1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
Former names
Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
  1. PRER14A Other PRER14A
  2. NT 10-Q Other NT 10-Q
  3. DEFA14A Proxy Proxy Materials
  4. DEFA14A Proxy Proxy Materials
  5. NT 10-Q Other NT 10-Q
  6. NT 10-K Other NT 10-K
  7. EFFECT Other Notice of Effectiveness
  8. FWP Offering Free Writing Prospectus
  9. EFFECT Other Notice of Effectiveness
  10. D Other Notice of Sales of Unregistered Securities
  11. NT 10-K Other NT 10-K
  12. EFFECT Other Notice of Effectiveness
  13. FWP Offering Free Writing Prospectus
  14. NT 10-Q Other NT 10-Q
  15. DEFA14A Proxy Proxy Materials
  16. EFFECT Other Notice of Effectiveness
  17. CERTNAS Other Certification by the Nasdaq Stock Market
  18. 8-A12B Other Registration of Securities
  19. FWP Offering Free Writing Prospectus
  20. REGDEX Other REGDEX

Page 3 of 4 · 61 filings